The results from human tissue verification of the two target genes showed that the gene expression level was lower in EBVaGC compared with that in non-tumor tissues for GDF5 (P = 0.043), and marginal difference was also observed between EBVaGC and EBVnGC (P = 0.076). This evidence concerns the gene GDF5 and neoplasm.